These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11363513)

  • 21. Nipping HIV in the bud.
    Smart T
    GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):7. PubMed ID: 11363052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dethroning AZT.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):10-3. PubMed ID: 11364106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; (3):CD002038. PubMed ID: 10908523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Which is the strategy? The latest in the use of antiretrovirals].
    Agosto M
    Sidahora; 1995; ():33-4. PubMed ID: 11363205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 32. ACTG 175: new insights into treating patients with intermediate-stage HIV disease.
    Folkers G
    NIAID AIDS Agenda; 1995 Dec; ():4-5. PubMed ID: 11363352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
    Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ddI plus d4T.
    James JS
    AIDS Treat News; 1996 Sep; (No 254):4. PubMed ID: 11363818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3TC: combination trial stopped early as clinical benefit shown.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New trials reach same conclusion: two drugs are better than AZT alone.
    AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Weak antiviral effect of changing two nucleoside analogues combined with antiretroviral agents. 3TC and d4T after ZDU and ddi or ddc].
    Rey D; Schmitt AC; Schmitt MP; Partisani M; Nicolle M; Kempf-Durepaire G; Krantz V; Lang JM
    Presse Med; 1998 Feb; 27(8):360. PubMed ID: 9768003
    [No Abstract]   [Full Text] [Related]  

  • 38. Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
    Mathe G; Morette C; Hallard M; Pontiggia P; Blanquet D; Hage F
    Acta Pharmacol Sin; 2002 Jan; 23(1):1-15. PubMed ID: 11860730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining d4T/ddI looks promising.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.